Brief: Organon To Acquire Dermavant Including Its Innovative Dermatologic Therapy, Vtama® (Tapinarof) Cream, 1%

Roivant Sciences

18/09/2024 13:45

Sept 18 (Reuters) - Organon & Co  OGN.N :
    * ORGANON TO ACQUIRE DERMAVANT INCLUDING ITS INNOVATIVE
DERMATOLOGIC THERAPY, VTAMA® (TAPINAROF) CREAM, 1%
    * ORGANON & CO - DEAL VALUED AT UP TO $1.2 BILLION
    * ORGANON & CO: DEAL TO BE MODESTLY DILUTIVE TO ADJUSTED
EBITDA IN
2025, TURNING ACCRETIVE IN 2026
    * ORGANON & CO-FDA REVIEWING SNDA FOR VTAMA CREAM AS
POTENTIAL
TREATMENT FOR AD IN ADULTS & CHILDREN 2 YRS OF AGE &OLDER,WITH
PDUFA ACTION SEES IN Q4

Source text for Eikon:  ID:nGNXbSPb7s 
Further company coverage:  OGN.N 

 ((Reuters.Briefs@thomsonreuters.com;))